Omnic Ocas 0.4 mg 30 tablets

Trade name:

Omnic Ocas

Composition

Each tablet contains:

0.4 mg tamsulosin hydrochloride

Auxiliary components:

Macrogol, magnesium stearate, colodial silicon, hypromellose.

Properties

Al-adrenergic receptor blocker; a remedy for the symptomatic treatment of benign prostatic hyperplasia.

Selectively blocks postsynaptic alAadrenergic receptors of smooth muscles of the prostate gland, bladder neck, prostatic urethra. As a result, the tone of the smooth muscles of these formations decreases, and the outflow of urine is facilitated. At the same time, the symptoms of obstruction and irritation associated with benign prostatic hyperplasia are reduced. The therapeutic effect appears approximately 2 weeks after the start of treatment.

The ability to block alB-adrenergic receptors of vascular smooth muscles is much less pronounced in tamsulosin, therefore the eff on systemic blood pressure is insignificant.

Indications

Benign prostatic hyperplasia.

Method of administration and dosage:

The optimal dosage regimen is determined by the doctor. The compliance of the used dosage form of a particular drug with indications for use and dosage regimen should be strictly observed.

Side effects

From the side of the cardiovascular system: rarely — dizziness, orthostatic hypotension, palpitations.

From the side of the central nervous system: possible headache, asthenia.

From the reproductive system: rarely retrograde ejaculation.